Darbecon 25mcg Injection
Marketer
Concord Biotech Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Darbecon 25mcg Injection
Erythropoietin alfa 25mcg Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. This medication requires careful administration due to potential serious adverse effects; expert medical supervision is crucial. Adhere strictly to your physician's instructions. Administration is always under professional healthcare guidance. Common side effects include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests will monitor electrolyte (potassium) levels, hemoglobin, and blood cell counts. Discontinue use and seek medical advice if shortness of breath or a skin rash develops. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or strokes. Pregnant or breastfeeding individuals, or those planning pregnancy or breastfeeding, must consult their physician regarding safety.
Uses of Darbecon 25mcg Injection
Managing anemia associated with chronic kidney failure | Addressing anemia resulting from cancer treatment with chemotherapy
Major Benefits of Darbecon 25mcg Injection:
Administering this medication will be done by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Darbecon 25mcg Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbecon 25mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Darbecon 25mcg Injection works:
Darbecon 25mcg Injection is an erythropoietin-based medication that boosts red blood cell production. It acts by prompting increased red blood cell generation within the bone marrow, the blood cell-producing tissue found inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Darbecon 25mcg Injection is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbecon 25mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Darbecon 25mcg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Darbecon 25mcg Injection.
KidneySAFE IF PRESCRIBED
Darbecon 25mcg Injection poses no safety concerns for patients with renal impairment; no dosage modification is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of Darbecon 25mcg Injection requires careful monitoring. Dosage modification of Darbecon 25mcg Injection may be necessary. Physician consultation is advised.
What if you forget to take Darbecon 25mcg Injection :
Should you forget a Darbecon 25mcg Injection dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbecon 25mcg Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
3,018 People bought this recently